DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

2021年1月29日 (金) 午前 10:00 - 2021年1月29日 (金) 午後 6:30

Online

8th DIA Cardiac Safety Workshop in Japan

[Session 3]Cardiovascular risk assessment of antitumor drugs

Session Chair(s)

Keita  Fujikawa

Keita Fujikawa

Head of General Medicine, Japan Medical Office

Takeda Pharmaceutical Company Limited, Japan

Yuji  Kumagai, MD, PhD

Yuji Kumagai, MD, PhD

Professor, Kitasato Clinical Research Center

Kitasato University Hospital, Japan

Speaker(s)

Tadahiro  Shinozawa, PhD

Safety translational research for cardio-oncology using iPS cells

Tadahiro Shinozawa, PhD

Takeda Pharmaceutical Company Limited, Japan

Associate Director, Drug Safety Research Lab, Regenerative Medicine Unit

Yoshito  Zamami

Development of preventive treatment against anticancer drug-induced side effects using big data analysis

Yoshito Zamami

Tokushima University Graduate School, Japan

Associate professor, Department of Clinical Pharmacology and Therapeutics,

Hideaki  Takahashi

Cardiovascular risk assessment of antitumor drugs

Hideaki Takahashi

Pharmacheuticals and Medical Devices Agency, Japan

Reviewer

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。